HKSE - Delayed Quote HKD
Brii Biosciences Limited (2137.HK)
2.000
+0.150
+(8.11%)
At close: April 25 at 4:08:21 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-466,041
-594,014
-496,279
-879,457
-403,716
Investing Cash Flow
642,967
-104,350
-1,433,168
-475,756
-43,650
Financing Cash Flow
-10,617
-10,977
-3,042
3,230,134
657,001
End Cash Position
653,803
489,650
1,190,572
2,855,093
1,034,965
Capital Expenditure
--
-49,608
-139,292
-1,029
--
Issuance of Capital Stock
92
179
7,447
3,327,684
668,528
Repurchase of Capital Stock
--
-1,162
-678
--
--
Free Cash Flow
-516,414
-643,622
-635,571
-880,486
-403,716
12/31/2020 - 7/13/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
UJ9.F Shandong Boan Biotechnology Co., Ltd.
1.1300
-0.88%
6978.HK Immunotech Biopharm Ltd
4.150
+1.97%
2511.HK HighTide Therapeutics, Inc.
1.700
-7.10%
6628.HK Transcenta Holding Limited
1.200
-6.25%
6660.HK AIM Vaccine Co., Ltd.
3.290
-2.95%
19X.F Axsome Therapeutics, Inc.
92.34
+1.85%
1877.HK JUNSHI BIO
15.420
-3.50%
1477.HK OCUMENSION-B
5.520
-0.18%
9966.HK Alphamab Oncology
6.910
-0.43%
9939.HK Kintor Pharmaceutical Limited
1.170
-3.31%